These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 21792197)
1. FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy. Day FL; Link E; Ngan S; Leong T; Moodie K; Lynch C; Michael M; Winton Ed; Hogg A; Hicks RJ; Heriot A Br J Cancer; 2011 Aug; 105(4):498-504. PubMed ID: 21792197 [TBL] [Abstract][Full Text] [Related]
2. Role of Houard C; Pinaquy JB; Mesguich C; Henriques de Figueiredo B; Cazeau AL; Allard JB; Laharie H; Bordenave L; Fernandez P; Vendrely V J Nucl Med; 2017 Sep; 58(9):1414-1420. PubMed ID: 28280225 [TBL] [Abstract][Full Text] [Related]
3. Prognostic utility of pre- and post-treatment FDG-PET parameters in anal squamous cell carcinoma. Duimering A; Riauka T; Nijjar Y; Ghosh S; MacEwan R; Warkentin H; Schiller D; Tankel K; Usmani N; Severin D; Nijjar T; Fairchild A; Mulder K; Doll C; Wong C; Joseph K Radiother Oncol; 2019 Jul; 136():21-28. PubMed ID: 31015125 [TBL] [Abstract][Full Text] [Related]
4. The predictive value of Mattoli MV; Massaccesi M; Castelluccia A; Scolozzi V; Mantini G; Calcagni ML Radiat Oncol; 2017 Jan; 12(1):4. PubMed ID: 28057034 [TBL] [Abstract][Full Text] [Related]
5. Assessment of tumor response to chemoradiotherapy and predicting prognosis in patients with head and neck squamous cell carcinoma by PERCIST. Katsuura T; Kitajima K; Fujiwara M; Terada T; Uwa N; Noguchi K; Doi H; Tamaki Y; Yoshida R; Tsuchitani T; Fujita M; Yamakado K Ann Nucl Med; 2018 Aug; 32(7):453-462. PubMed ID: 29858797 [TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of Combet-Curt V; Buchalet C; Le Malicot K; Lemanski C; Deshayes E; Bonichon-Lamichhane N; Lièvre A; Huguet F; Tlili G; Vendrely V J Nucl Med; 2024 Aug; 65(8):1194-1201. PubMed ID: 38936973 [TBL] [Abstract][Full Text] [Related]
7. Tumor response and survival predicted by post-therapy FDG-PET/CT in anal cancer. Schwarz JK; Siegel BA; Dehdashti F; Myerson RJ; Fleshman JW; Grigsby PW Int J Radiat Oncol Biol Phys; 2008 May; 71(1):180-6. PubMed ID: 17996387 [TBL] [Abstract][Full Text] [Related]
8. Role of 18F-FDG PET-derived parameters for predicting complete response to chemoradiotherapy in squamous cell anal carcinoma. Filippi L; Fontana A; Spinelli GP; Rossi L; Bagni O Nucl Med Commun; 2020 Oct; 41(10):1089-1094. PubMed ID: 32732599 [TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of tumour burden assessed by metabolic tumour volume on FDG PET/CT in anal canal cancer. Gauthé M; Richard-Molard M; Fayard J; Alberini JL; Cacheux W; Lièvre A Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):63-70. PubMed ID: 27503193 [TBL] [Abstract][Full Text] [Related]
10. Definitive chemoradiotherapy for anal canal cancer: single-center experience. Tachibana I; Nishimura Y; Inada M; Fukuda K; Ishikawa K; Nishikawa T; Yokokawa M; Nakamatsu K; Kanamori S; Hida JI Int J Clin Oncol; 2018 Dec; 23(6):1121-1126. PubMed ID: 29992389 [TBL] [Abstract][Full Text] [Related]
11. Prospective Study of Serial Imaging Comparing Fluorodeoxyglucose Positron Emission Tomography (PET) and Fluorothymidine PET During Radical Chemoradiation for Non-Small Cell Lung Cancer: Reduction of Detectable Proliferation Associated With Worse Survival. Everitt S; Ball D; Hicks RJ; Callahan J; Plumridge N; Trinh J; Herschtal A; Kron T; Mac Manus M Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):947-955. PubMed ID: 29063854 [TBL] [Abstract][Full Text] [Related]
12. FDG-PET/CT Predicts Outcome in Oropharingeal Carcinoma Patients Undergoing Intensity Modulated Radiation Therapy with Dose Escalation to FDG-avid Tumour Volumes. Mapelli P; Broggi S; Incerti E; Alongi P; Kirienko M; Fiorino C; Dell Oca I; Fallanca F; Vanoli EG; Di Muzio NG; Gianolli L; Picchio M Curr Radiopharm; 2017 Aug; 10(2):102-110. PubMed ID: 28412923 [TBL] [Abstract][Full Text] [Related]
13. Metabolic response on post-therapy FDG-PET predicts patterns of failure after radiotherapy for cervical cancer. Schwarz JK; Siegel BA; Dehdashti F; Grigsby PW Int J Radiat Oncol Biol Phys; 2012 May; 83(1):185-90. PubMed ID: 22014958 [TBL] [Abstract][Full Text] [Related]
14. Metabolic tumour volume of anal carcinoma on (18)FDG PET/CT before combined radiochemotherapy is the only independant determinant of recurrence free survival. Mohammadkhani Shali S; Schmitt V; Behrendt FF; Winz OH; Heinzel A; Mottaghy FM; Eble MJ; Verburg FA Eur J Radiol; 2016 Aug; 85(8):1390-4. PubMed ID: 27423677 [TBL] [Abstract][Full Text] [Related]
15. Outcomes of patients with esophageal cancer staged with [¹⁸F]fluorodeoxyglucose positron emission tomography (FDG-PET): can postchemoradiotherapy FDG-PET predict the utility of resection? Monjazeb AM; Riedlinger G; Aklilu M; Geisinger KR; Mishra G; Isom S; Clark P; Levine EA; Blackstock AW J Clin Oncol; 2010 Nov; 28(31):4714-21. PubMed ID: 20876421 [TBL] [Abstract][Full Text] [Related]
16. Combined PET-CT and MRI for response evaluation in patients with squamous cell anal carcinoma treated with curative-intent chemoradiotherapy. Adusumilli P; Elsayed N; Theophanous S; Samuel R; Cooper R; Casanova N; Tolan DJ; Gilbert A; Scarsbrook AF Eur Radiol; 2022 Aug; 32(8):5086-5096. PubMed ID: 35274187 [TBL] [Abstract][Full Text] [Related]
17. Utility of Arnett ALH; Merrell KW; Macintosh EM; James SE; Nathan MA; Shen KR; Ravi K; Neben Wittich MA; Haddock MG; Hallemeier CL J Thorac Oncol; 2017 Jan; 12(1):121-128. PubMed ID: 27569732 [TBL] [Abstract][Full Text] [Related]
18. Posttreatment FDG-PET-CT response is predictive of tumor progression and survival in anal carcinoma. Goldman KE; White EC; Rao AR; Kaptein JS; Lien WW Pract Radiat Oncol; 2016; 6(5):e149-e154. PubMed ID: 26948134 [TBL] [Abstract][Full Text] [Related]
19. The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer. Winton Ed; Heriot AG; Ng M; Hicks RJ; Hogg A; Milner A; Leong T; Fay M; MacKay J; Drummond E; Ngan SY Br J Cancer; 2009 Mar; 100(5):693-700. PubMed ID: 19259091 [TBL] [Abstract][Full Text] [Related]
20. Value of complete metabolic response by (18)F-fluorodeoxyglucose-positron emission tomography in oesophageal cancer for prediction of pathologic response and survival after preoperative chemoradiotherapy. Kim MK; Ryu JS; Kim SB; Ahn JH; Kim SY; Park SI; Kim YH; Song HY; Shin JH; Jung HY; Lee GH; Choi KD; Cho KJ; Kim JH Eur J Cancer; 2007 Jun; 43(9):1385-91. PubMed ID: 17512192 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]